Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV01E Booster in Adults
NCT05308576Phase 3Active, not recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Dec 2022
- Primary completion
- May 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SCTV01E in coronavirus disease 2019 (COVID-19), sponsored by Sinocelltech Group Limited. Started Dec 2022; status: active, not recruiting.
02
Drugs
SCTV01E
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05308576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308576.